Literature DB >> 7448751

Statistical methods for the analysis of tumor multiplicity data.

N R Drinkwater, J H Klotz.   

Abstract

The fit of tumor multiplicity data from 93 mouse skin, lung, and liver carcinogenicity experiments to Poisson, negative binomial, and normal distributions was studied. The data were fitted well by the negative binomial distribution. This distribution has two parameters, the mean tumor multiplicity and an exponent determined by the interanimal homogeneity of tumor response. The value of the latter parameter was related to animal strain and the target tissue studied in the carcinogenicity experiments. The null distribution of the two-sample likelihood ratio test based on the negative binomial with common exponent model for tumor multiplicity data was shown by simulation studies to be approximately chi 2 with 1 d.f. Simulation also indicated that the likelihood ratio test has sufficiently better performance when the negative binomial model is valid to make its use more attractive than the more commonly used Wilcoxon test or Student t test. Charts for estimating the number of animals per group that are required to detect specified differences in tumor multiplicities are provided for several commonly used assays.

Entities:  

Mesh:

Year:  1981        PMID: 7448751

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Rank-based statistical methodologies for quantitative trait locus mapping.

Authors:  Fei Zou; Brian S Yandell; Jason P Fine
Journal:  Genetics       Date:  2003-11       Impact factor: 4.562

2.  Two genes abrogate the inhibition of murine hepatocarcinogenesis by ovarian hormones.

Authors:  T M Poole; N R Drinkwater
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Enhancement of hepatocarcinogenesis in rainbow trout with carbon tetrachloride.

Authors:  N Kotsanis; C D Metcalfe
Journal:  Bull Environ Contam Toxicol       Date:  1991-06       Impact factor: 2.151

4.  A subset of skin tumor modifier loci determines survival time of tumor-bearing mice.

Authors:  H Nagase; J H Mao; A Balmain
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

5.  A nonparametric approach for mapping quantitative trait loci.

Authors:  L Kruglyak; E S Lander
Journal:  Genetics       Date:  1995-03       Impact factor: 4.562

6.  Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat.

Authors:  H Lan; C M Kendziorski; J D Haag; L A Shepel; M A Newton; M N Gould
Journal:  Genetics       Date:  2001-01       Impact factor: 4.562

7.  Identification of hepatocarcinogen-resistance genes in DBA/2 mice.

Authors:  G H Lee; L M Bennett; R A Carabeo; N R Drinkwater
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

8.  Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2.

Authors:  Urszula Dougherty; Dario Cerasi; Ieva Taylor; Masha Kocherginsky; Ummuhan Tekin; Shamiram Badal; Lata Aluri; Amikar Sehdev; Sonia Cerda; Reba Mustafi; Jorge Delgado; Loren Joseph; Hongyan Zhu; John Hart; David Threadgill; Alessandro Fichera; Marc Bissonnette
Journal:  Clin Cancer Res       Date:  2009-11-10       Impact factor: 12.531

9.  American ginseng suppresses Western diet-promoted tumorigenesis in model of inflammation-associated colon cancer: role of EGFR.

Authors:  Urszula Dougherty; Reba Mustafi; Yunwei Wang; Mark W Musch; Chong-Zhi Wang; Vani J Konda; Anirudh Kulkarni; John Hart; Glyn Dawson; Karen E Kim; Chun-Su Yuan; Eugene B Chang; Marc Bissonnette
Journal:  BMC Complement Altern Med       Date:  2011-11-09       Impact factor: 3.659

10.  Comparison of the tumorigenic response of SENCAR and C57BL/6 mice to benzo(a)pyrene and the inter-experimental variability over a three-year period.

Authors:  S Nesnow; H Bergman; T J Slaga
Journal:  Environ Health Perspect       Date:  1986-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.